Successful Use of Fosmanogepix for Treatment of Rare Highly Resistant Cutaneous Fusariosis in a Pediatric Patient With STAT3 Hyper-Immunoglobulin E Syndrome and End-Stage Kidney Disease

We describe the successful use of the novel antifungal drug fosmanogepix to treat a chronic case of multidrug-resistant cutaneous Fusarium suttonianum infection in a pediatric patient with STAT3 hyper-IgE syndrome and end-stage kidney disease on peritoneal dialysis.

Detalles Bibliográficos
Autores principales: Goggin, Kathryn P, Londeree, Jackson, Freeman, Alexandra F, Garro, Rouba, George, Roshan P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Novel ID Cases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249262/
https://www.ncbi.nlm.nih.gov/pubmed/37305844
http://dx.doi.org/10.1093/ofid/ofad285
_version_ 1785055522995568640
author Goggin, Kathryn P
Londeree, Jackson
Freeman, Alexandra F
Garro, Rouba
George, Roshan P
author_facet Goggin, Kathryn P
Londeree, Jackson
Freeman, Alexandra F
Garro, Rouba
George, Roshan P
author_sort Goggin, Kathryn P
collection PubMed
description We describe the successful use of the novel antifungal drug fosmanogepix to treat a chronic case of multidrug-resistant cutaneous Fusarium suttonianum infection in a pediatric patient with STAT3 hyper-IgE syndrome and end-stage kidney disease on peritoneal dialysis.
format Online
Article
Text
id pubmed-10249262
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-102492622023-06-09 Successful Use of Fosmanogepix for Treatment of Rare Highly Resistant Cutaneous Fusariosis in a Pediatric Patient With STAT3 Hyper-Immunoglobulin E Syndrome and End-Stage Kidney Disease Goggin, Kathryn P Londeree, Jackson Freeman, Alexandra F Garro, Rouba George, Roshan P Open Forum Infect Dis Novel ID Cases We describe the successful use of the novel antifungal drug fosmanogepix to treat a chronic case of multidrug-resistant cutaneous Fusarium suttonianum infection in a pediatric patient with STAT3 hyper-IgE syndrome and end-stage kidney disease on peritoneal dialysis. Oxford University Press 2023-05-23 /pmc/articles/PMC10249262/ /pubmed/37305844 http://dx.doi.org/10.1093/ofid/ofad285 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Novel ID Cases
Goggin, Kathryn P
Londeree, Jackson
Freeman, Alexandra F
Garro, Rouba
George, Roshan P
Successful Use of Fosmanogepix for Treatment of Rare Highly Resistant Cutaneous Fusariosis in a Pediatric Patient With STAT3 Hyper-Immunoglobulin E Syndrome and End-Stage Kidney Disease
title Successful Use of Fosmanogepix for Treatment of Rare Highly Resistant Cutaneous Fusariosis in a Pediatric Patient With STAT3 Hyper-Immunoglobulin E Syndrome and End-Stage Kidney Disease
title_full Successful Use of Fosmanogepix for Treatment of Rare Highly Resistant Cutaneous Fusariosis in a Pediatric Patient With STAT3 Hyper-Immunoglobulin E Syndrome and End-Stage Kidney Disease
title_fullStr Successful Use of Fosmanogepix for Treatment of Rare Highly Resistant Cutaneous Fusariosis in a Pediatric Patient With STAT3 Hyper-Immunoglobulin E Syndrome and End-Stage Kidney Disease
title_full_unstemmed Successful Use of Fosmanogepix for Treatment of Rare Highly Resistant Cutaneous Fusariosis in a Pediatric Patient With STAT3 Hyper-Immunoglobulin E Syndrome and End-Stage Kidney Disease
title_short Successful Use of Fosmanogepix for Treatment of Rare Highly Resistant Cutaneous Fusariosis in a Pediatric Patient With STAT3 Hyper-Immunoglobulin E Syndrome and End-Stage Kidney Disease
title_sort successful use of fosmanogepix for treatment of rare highly resistant cutaneous fusariosis in a pediatric patient with stat3 hyper-immunoglobulin e syndrome and end-stage kidney disease
topic Novel ID Cases
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249262/
https://www.ncbi.nlm.nih.gov/pubmed/37305844
http://dx.doi.org/10.1093/ofid/ofad285
work_keys_str_mv AT gogginkathrynp successfuluseoffosmanogepixfortreatmentofrarehighlyresistantcutaneousfusariosisinapediatricpatientwithstat3hyperimmunoglobulinesyndromeandendstagekidneydisease
AT londereejackson successfuluseoffosmanogepixfortreatmentofrarehighlyresistantcutaneousfusariosisinapediatricpatientwithstat3hyperimmunoglobulinesyndromeandendstagekidneydisease
AT freemanalexandraf successfuluseoffosmanogepixfortreatmentofrarehighlyresistantcutaneousfusariosisinapediatricpatientwithstat3hyperimmunoglobulinesyndromeandendstagekidneydisease
AT garrorouba successfuluseoffosmanogepixfortreatmentofrarehighlyresistantcutaneousfusariosisinapediatricpatientwithstat3hyperimmunoglobulinesyndromeandendstagekidneydisease
AT georgeroshanp successfuluseoffosmanogepixfortreatmentofrarehighlyresistantcutaneousfusariosisinapediatricpatientwithstat3hyperimmunoglobulinesyndromeandendstagekidneydisease

Ejemplares similares